13 September 2023 - Company isn’t primary manufacturer, administration argues.
The Biden administration is urging a federal court to rule in its favour in a legal battle with Merck over a plan to lower Medicare drug prices that has drawn the ire of the broader pharmaceutical industry, claiming the drug maker misunderstands the law and isn’t in a position to sue.